KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Change in Cash (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Change in Cash for 17 consecutive years, with $134.0 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 72.68% to $134.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.4 million through Dec 2025, down 50.35% year-over-year, with the annual reading at $42.4 million for FY2025, 50.35% down from the prior year.
  • Change in Cash for Q4 2025 was $134.0 million at Bio-Rad Laboratories, up from $26.5 million in the prior quarter.
  • The five-year high for Change in Cash was $331.5 million in Q1 2022, with the low at -$393.4 million in Q4 2021.
  • Average Change in Cash over 5 years is -$6.7 million, with a median of $18.5 million recorded in 2021.
  • The sharpest move saw Change in Cash soared 3030.82% in 2022, then tumbled 480.08% in 2025.
  • Over 5 years, Change in Cash stood at -$393.4 million in 2021, then soared by 78.72% to -$83.7 million in 2022, then surged by 35.65% to -$53.9 million in 2023, then skyrocketed by 244.05% to $77.6 million in 2024, then surged by 72.68% to $134.0 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at $134.0 million, $26.5 million, and -$151.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.